Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disorder of the central nervous system (CNS). The detection of NMO IgG autoantibody, which targets the aquaporin-4 water channel, distinguishes NMO from multiple sclerosis. The mRNA levels of inflammasome related genes were increased in active frozen spinal cord tissues of NMOSD. Moreover, sorted lymphocytes from peripheral blood in patients with NMOSD also had the increased mRNA expression of inflammasome related genes and interferon-gamma. These data suggest that innate immunity including inflammasome play an might important role in the pathomechanism of NMOSD.
|